Back to Journals » Drug Design, Development and Therapy » Volume 12

Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma

Total article views   HTML views PDF downloads Totals
19,470 Dovepress* 14,937+ 1,584 16,521
PubMed Central* 4,533 1,058 5,591
Totals 19,470 2,642 22,112
*Since 23 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 1 7

View citations on PubMed Central and Google Scholar